|Bid||2.9000 x 800|
|Ask||3.0300 x 1800|
|Day's Range||2.8924 - 3.0300|
|52 Week Range||2.4000 - 14.4000|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2021 - Aug 16, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.63|
ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Trademark Office (USPTO) recently issued U.
* Meeting scheduled to reconvene June 23, 2021 at 12:00 PM Eastern Time * Company encourages stockholders to cast their votesENGLEWOOD, CO / ACCESSWIRE / June 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it has adjourned its 2021 Annual Meeting of Stockholders for a second time due to a lack of quorum.
Pivotal SUI PURSUIT trial enrollment underway and acceleratingTotal revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific marketsENGLEWOOD, CO / ACCESSWIRE / May 13, 2021 / Viveve Medical, Inc.